PRF Technologies Announces PRF-110 Demonstrated Sustained 72-Hour Analgesic Activity Comparable to Approved, Commercially Available Benchmark in Head-to-Head Preclinical Study
Go back to PRF Technologies Announces PRF-110 Demonstrated Sustained 72-Hour Analgesic Activity Comparable to Approved, Commercially Available Benchmark in Head-to-Head Preclinical Study| (NASDAQ: PRFX) | Delayed: 1.60 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.60 | 52 Week High | $ | |||
| Open | $1.60 | 52 Week Low | $ | |||
| Day High | $1.60 | P/E | N/A | |||
| Day Low | $1.60 | EPS | $ | |||
| Volume | 6,608 | |||||

